Ciprofloxacin Pharmacokinetics in Critically Ill Patients Receiving Concomitant Continuous Venovenous Hemodialysis
Gespeichert in:
Veröffentlicht in: | American journal of kidney diseases 2015-07, Vol.66 (1), p.173-175 |
---|---|
Hauptverfasser: | , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 175 |
---|---|
container_issue | 1 |
container_start_page | 173 |
container_title | American journal of kidney diseases |
container_volume | 66 |
creator | Shotwell, Matthew S., PhD Madonia, Phillip N., MD Connor, Michael J., MD Amde, Milen, MD Salem, Charbel, MD Aduroja, Olufemi A., MD Bauer, Seth R., PharmD Groszek, Joseph J., BS Fissell, William H., MD |
description | |
doi_str_mv | 10.1053/j.ajkd.2015.03.001 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1691597824</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0272638615005223</els_id><sourcerecordid>1691597824</sourcerecordid><originalsourceid>FETCH-LOGICAL-c481t-d5d84b43c577468f2834acb00c31205921cd3d138fff26751a042a217d9f5dcd3</originalsourceid><addsrcrecordid>eNp9kU-P1SAUxYnROM_RL-DCdOmm9QKlpYkxMY06k0zixH9bwgOq9FEYgb74vr00b3ThwgXhBM65ufd3EXqOocHA6Ku5kfNBNwQwa4A2APgB2mFGaN1xyh-iHZCe1B3l3QV6ktIMAAPtusfogrABE97CDsXR3sUwufBLKuur2x8yLlKFg_UmW5Wq8jZGW6R07lRdO1fdymyNz6n6ZJSxR-u_V2PwKiw2S583na1fw5qqb8aHYzlFXpklaCvdKdn0FD2apEvm2f19ib6-f_dlvKpvPn64Ht_e1KrlONeaad7uW6pY37cdnwinrVR7AEUxATYQrDTVmPJpmkjXMyyhJZLgXg8T0-XvEr081y0D_lxNymKxSRnnpDelJ4G7AbOh56QtVnK2qhhSimYSd9EuMp4EBrGxFrPYWIuNtQAqCusSenFff90vRv-N_IFbDK_PBlOmPFoTRVIFnTLaRqOy0MH-v_6bf-LKWb9t4mBOJs1hjb7wE1gkIkB83ra9LRszAEYIpb8BLNOmuA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1691597824</pqid></control><display><type>article</type><title>Ciprofloxacin Pharmacokinetics in Critically Ill Patients Receiving Concomitant Continuous Venovenous Hemodialysis</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Shotwell, Matthew S., PhD ; Madonia, Phillip N., MD ; Connor, Michael J., MD ; Amde, Milen, MD ; Salem, Charbel, MD ; Aduroja, Olufemi A., MD ; Bauer, Seth R., PharmD ; Groszek, Joseph J., BS ; Fissell, William H., MD</creator><creatorcontrib>Shotwell, Matthew S., PhD ; Madonia, Phillip N., MD ; Connor, Michael J., MD ; Amde, Milen, MD ; Salem, Charbel, MD ; Aduroja, Olufemi A., MD ; Bauer, Seth R., PharmD ; Groszek, Joseph J., BS ; Fissell, William H., MD</creatorcontrib><identifier>ISSN: 0272-6386</identifier><identifier>EISSN: 1523-6838</identifier><identifier>DOI: 10.1053/j.ajkd.2015.03.001</identifier><identifier>PMID: 25912840</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Aged ; Anti-Bacterial Agents - blood ; Anti-Bacterial Agents - pharmacokinetics ; Anti-Bacterial Agents - therapeutic use ; Area Under Curve ; Bacterial Infections - drug therapy ; Bacterial Infections - mortality ; Ciprofloxacin - blood ; Ciprofloxacin - pharmacokinetics ; Ciprofloxacin - therapeutic use ; Critical Illness - mortality ; Dose-Response Relationship, Drug ; Drug Resistance, Microbial ; Female ; Humans ; Male ; Metabolic Clearance Rate ; Microbial Sensitivity Tests ; Middle Aged ; Nephrology ; Prospective Studies ; Renal Dialysis - methods</subject><ispartof>American journal of kidney diseases, 2015-07, Vol.66 (1), p.173-175</ispartof><rights>National Kidney Foundation, Inc.</rights><rights>2015 National Kidney Foundation, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c481t-d5d84b43c577468f2834acb00c31205921cd3d138fff26751a042a217d9f5dcd3</citedby><cites>FETCH-LOGICAL-c481t-d5d84b43c577468f2834acb00c31205921cd3d138fff26751a042a217d9f5dcd3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1053/j.ajkd.2015.03.001$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25912840$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Shotwell, Matthew S., PhD</creatorcontrib><creatorcontrib>Madonia, Phillip N., MD</creatorcontrib><creatorcontrib>Connor, Michael J., MD</creatorcontrib><creatorcontrib>Amde, Milen, MD</creatorcontrib><creatorcontrib>Salem, Charbel, MD</creatorcontrib><creatorcontrib>Aduroja, Olufemi A., MD</creatorcontrib><creatorcontrib>Bauer, Seth R., PharmD</creatorcontrib><creatorcontrib>Groszek, Joseph J., BS</creatorcontrib><creatorcontrib>Fissell, William H., MD</creatorcontrib><title>Ciprofloxacin Pharmacokinetics in Critically Ill Patients Receiving Concomitant Continuous Venovenous Hemodialysis</title><title>American journal of kidney diseases</title><addtitle>Am J Kidney Dis</addtitle><subject>Aged</subject><subject>Anti-Bacterial Agents - blood</subject><subject>Anti-Bacterial Agents - pharmacokinetics</subject><subject>Anti-Bacterial Agents - therapeutic use</subject><subject>Area Under Curve</subject><subject>Bacterial Infections - drug therapy</subject><subject>Bacterial Infections - mortality</subject><subject>Ciprofloxacin - blood</subject><subject>Ciprofloxacin - pharmacokinetics</subject><subject>Ciprofloxacin - therapeutic use</subject><subject>Critical Illness - mortality</subject><subject>Dose-Response Relationship, Drug</subject><subject>Drug Resistance, Microbial</subject><subject>Female</subject><subject>Humans</subject><subject>Male</subject><subject>Metabolic Clearance Rate</subject><subject>Microbial Sensitivity Tests</subject><subject>Middle Aged</subject><subject>Nephrology</subject><subject>Prospective Studies</subject><subject>Renal Dialysis - methods</subject><issn>0272-6386</issn><issn>1523-6838</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kU-P1SAUxYnROM_RL-DCdOmm9QKlpYkxMY06k0zixH9bwgOq9FEYgb74vr00b3ThwgXhBM65ufd3EXqOocHA6Ku5kfNBNwQwa4A2APgB2mFGaN1xyh-iHZCe1B3l3QV6ktIMAAPtusfogrABE97CDsXR3sUwufBLKuur2x8yLlKFg_UmW5Wq8jZGW6R07lRdO1fdymyNz6n6ZJSxR-u_V2PwKiw2S583na1fw5qqb8aHYzlFXpklaCvdKdn0FD2apEvm2f19ib6-f_dlvKpvPn64Ht_e1KrlONeaad7uW6pY37cdnwinrVR7AEUxATYQrDTVmPJpmkjXMyyhJZLgXg8T0-XvEr081y0D_lxNymKxSRnnpDelJ4G7AbOh56QtVnK2qhhSimYSd9EuMp4EBrGxFrPYWIuNtQAqCusSenFff90vRv-N_IFbDK_PBlOmPFoTRVIFnTLaRqOy0MH-v_6bf-LKWb9t4mBOJs1hjb7wE1gkIkB83ra9LRszAEYIpb8BLNOmuA</recordid><startdate>20150701</startdate><enddate>20150701</enddate><creator>Shotwell, Matthew S., PhD</creator><creator>Madonia, Phillip N., MD</creator><creator>Connor, Michael J., MD</creator><creator>Amde, Milen, MD</creator><creator>Salem, Charbel, MD</creator><creator>Aduroja, Olufemi A., MD</creator><creator>Bauer, Seth R., PharmD</creator><creator>Groszek, Joseph J., BS</creator><creator>Fissell, William H., MD</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20150701</creationdate><title>Ciprofloxacin Pharmacokinetics in Critically Ill Patients Receiving Concomitant Continuous Venovenous Hemodialysis</title><author>Shotwell, Matthew S., PhD ; Madonia, Phillip N., MD ; Connor, Michael J., MD ; Amde, Milen, MD ; Salem, Charbel, MD ; Aduroja, Olufemi A., MD ; Bauer, Seth R., PharmD ; Groszek, Joseph J., BS ; Fissell, William H., MD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c481t-d5d84b43c577468f2834acb00c31205921cd3d138fff26751a042a217d9f5dcd3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Aged</topic><topic>Anti-Bacterial Agents - blood</topic><topic>Anti-Bacterial Agents - pharmacokinetics</topic><topic>Anti-Bacterial Agents - therapeutic use</topic><topic>Area Under Curve</topic><topic>Bacterial Infections - drug therapy</topic><topic>Bacterial Infections - mortality</topic><topic>Ciprofloxacin - blood</topic><topic>Ciprofloxacin - pharmacokinetics</topic><topic>Ciprofloxacin - therapeutic use</topic><topic>Critical Illness - mortality</topic><topic>Dose-Response Relationship, Drug</topic><topic>Drug Resistance, Microbial</topic><topic>Female</topic><topic>Humans</topic><topic>Male</topic><topic>Metabolic Clearance Rate</topic><topic>Microbial Sensitivity Tests</topic><topic>Middle Aged</topic><topic>Nephrology</topic><topic>Prospective Studies</topic><topic>Renal Dialysis - methods</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Shotwell, Matthew S., PhD</creatorcontrib><creatorcontrib>Madonia, Phillip N., MD</creatorcontrib><creatorcontrib>Connor, Michael J., MD</creatorcontrib><creatorcontrib>Amde, Milen, MD</creatorcontrib><creatorcontrib>Salem, Charbel, MD</creatorcontrib><creatorcontrib>Aduroja, Olufemi A., MD</creatorcontrib><creatorcontrib>Bauer, Seth R., PharmD</creatorcontrib><creatorcontrib>Groszek, Joseph J., BS</creatorcontrib><creatorcontrib>Fissell, William H., MD</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>American journal of kidney diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Shotwell, Matthew S., PhD</au><au>Madonia, Phillip N., MD</au><au>Connor, Michael J., MD</au><au>Amde, Milen, MD</au><au>Salem, Charbel, MD</au><au>Aduroja, Olufemi A., MD</au><au>Bauer, Seth R., PharmD</au><au>Groszek, Joseph J., BS</au><au>Fissell, William H., MD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Ciprofloxacin Pharmacokinetics in Critically Ill Patients Receiving Concomitant Continuous Venovenous Hemodialysis</atitle><jtitle>American journal of kidney diseases</jtitle><addtitle>Am J Kidney Dis</addtitle><date>2015-07-01</date><risdate>2015</risdate><volume>66</volume><issue>1</issue><spage>173</spage><epage>175</epage><pages>173-175</pages><issn>0272-6386</issn><eissn>1523-6838</eissn><cop>United States</cop><pub>Elsevier Inc</pub><pmid>25912840</pmid><doi>10.1053/j.ajkd.2015.03.001</doi><tpages>3</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0272-6386 |
ispartof | American journal of kidney diseases, 2015-07, Vol.66 (1), p.173-175 |
issn | 0272-6386 1523-6838 |
language | eng |
recordid | cdi_proquest_miscellaneous_1691597824 |
source | MEDLINE; Access via ScienceDirect (Elsevier) |
subjects | Aged Anti-Bacterial Agents - blood Anti-Bacterial Agents - pharmacokinetics Anti-Bacterial Agents - therapeutic use Area Under Curve Bacterial Infections - drug therapy Bacterial Infections - mortality Ciprofloxacin - blood Ciprofloxacin - pharmacokinetics Ciprofloxacin - therapeutic use Critical Illness - mortality Dose-Response Relationship, Drug Drug Resistance, Microbial Female Humans Male Metabolic Clearance Rate Microbial Sensitivity Tests Middle Aged Nephrology Prospective Studies Renal Dialysis - methods |
title | Ciprofloxacin Pharmacokinetics in Critically Ill Patients Receiving Concomitant Continuous Venovenous Hemodialysis |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-03T22%3A00%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Ciprofloxacin%20Pharmacokinetics%20in%20Critically%20Ill%20Patients%20Receiving%20Concomitant%20Continuous%20Venovenous%20Hemodialysis&rft.jtitle=American%20journal%20of%20kidney%20diseases&rft.au=Shotwell,%20Matthew%20S.,%20PhD&rft.date=2015-07-01&rft.volume=66&rft.issue=1&rft.spage=173&rft.epage=175&rft.pages=173-175&rft.issn=0272-6386&rft.eissn=1523-6838&rft_id=info:doi/10.1053/j.ajkd.2015.03.001&rft_dat=%3Cproquest_cross%3E1691597824%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1691597824&rft_id=info:pmid/25912840&rft_els_id=1_s2_0_S0272638615005223&rfr_iscdi=true |